Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million
May 7 (Reuters) - Active Biotech AB publ ACTI.ST: REPORTS LOSS AFTER TAX OF SEK 8.4 MILLION FOR JAN-MAR 2026 CASH AND CASH EQUIVALENTS SEK 53.3 MILLION AT END OF JAN-MAR 2026 Source text: ID:nMFN33hVsX Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))